Petros Pharmaceuticals officer reports share holdings

Petros Pharmaceuticals, Inc. executive Robert Weinstein, the Chief Accounting Officer, has reported his existing holdings on a Form 3.

Rhea-AI Filing Summary

Petros Pharmaceuticals, Inc. executive Robert Weinstein, the Chief Accounting Officer, has reported his existing holdings on a Form 3. He holds a total of 636,004 shares of common stock, including restricted shares and restricted stock units.

His position includes 6,004 restricted shares, of which 3,004 are already vested and the remainder will vest on February 2, 2027. It also includes 315,000 vested restricted stock units (RSUs) and 315,000 unvested RSUs, with 2,500 scheduled to vest on July 2, 2026 and the rest on December 5, 2026.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider WEINSTEIN ROBERT

Role Chief Accounting Officer

Type	Security	Shares	Price	Value
holding	Common stock	--	--	--

Holdings After Transaction: Common stock — 636,004 shares (Direct)

Footnotes (1)

1. F1. Includes (i) 6,004 restricted shares of common stock, par value $0.0001, of the Issuer, of which 3,004 shares are vested and the remainder of which will vest on February 2, 2027, (ii) 315,000 vested restricted stock units ("RSUs"), and (iii) 315,000 unvested RSUs, 2,500 of which will vest on July 2, 2026 and the remainder of which will vest on December 5, 2026.

Key Figures

Common stock holdings: 636,004 shares Restricted shares: 6,004 shares Vested restricted shares: 3,004 shares +4 more

7 metrics

Common stock holdings 636,004 shares Total common stock reported following transaction

Restricted shares 6,004 shares Restricted common stock included in holdings

Vested restricted shares 3,004 shares Portion of restricted shares already vested

Vested RSUs 315,000 RSUs Restricted stock units that are vested

Unvested RSUs 315,000 RSUs Restricted stock units not yet vested

RSUs vesting July 2, 2026 2,500 RSUs First tranche of unvested RSUs vesting on July 2, 2026

Remaining RSUs vesting RSUs (balance of 315,000) Unvested RSUs vesting on December 5, 2026

Key Terms

restricted shares, restricted stock units ("RSUs"), Form 3, Chief Accounting Officer

4 terms

restricted shares financial

"Includes (i) 6,004 restricted shares of common stock, par value $0.0001, of the Issuer"

Restricted shares are company stock that cannot be sold or transferred immediately because they are subject to legal or contractual limits, such as a required holding period or performance conditions. They matter to investors because these locked-up shares can affect a company’s available stock for trading, future dilution, and insider incentives—imagine a gift that can’t be cashed until certain conditions are met, which changes when and how much supply can suddenly enter the market.

restricted stock units ("RSUs") financial

"315,000 vested restricted stock units ("RSUs"), and (iii) 315,000 unvested RSUs"

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

Form 3 regulatory

"has reported his existing holdings on a Form 3"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

Chief Accounting Officer financial

"Robert Weinstein, the Chief Accounting Officer, has reported his existing holdings"

A chief accounting officer is a senior executive responsible for overseeing a company's financial records and ensuring all accounting practices are accurate and compliant with regulations. They play a key role in preparing financial reports that help investors understand the company's financial health, much like a trusted navigator guiding a ship through complex waters. Their work ensures transparency and trust in the company's financial information.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the PTPI Form 3 filing by Robert Weinstein show?

The Form 3 shows that Chief Accounting Officer Robert Weinstein holds 636,004 shares of Petros Pharmaceuticals common stock, including restricted shares and restricted stock units. It records his existing ownership position as an insider rather than new share purchases or sales.

How many Petros Pharmaceuticals (PTPI) restricted shares does Robert Weinstein hold?

Robert Weinstein holds 6,004 restricted shares of Petros Pharmaceuticals common stock. Of these, 3,004 shares are already vested, while the remaining restricted shares are scheduled to vest on February 2, 2027, according to the Form 3 footnote disclosure.

How many RSUs does the PTPI Chief Accounting Officer report on Form 3?

The Chief Accounting Officer reports 630,000 restricted stock units (RSUs) in total. This consists of 315,000 vested RSUs and 315,000 unvested RSUs, providing a detailed breakdown of his equity-based compensation at Petros Pharmaceuticals.

When will Robert Weinstein’s unvested PTPI RSUs vest?

Of Robert Weinstein’s 315,000 unvested RSUs, 2,500 are scheduled to vest on July 2, 2026. The remaining unvested RSUs are expected to vest on December 5, 2026, based on the vesting schedule disclosed in the Form 3 footnote.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/25/2026 - 05:00 PM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

WEINSTEIN ROBERT

(Last) (First) (Middle)

1185 AVENUE OF THE AMERICAS,

3RD FLOOR

(Street)

NEW YORK NEW YORK 10036

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
06/18/2026

3. Issuer Name and Ticker or Trading Symbol
Petros Pharmaceuticals, Inc. [ PTPI ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Accounting Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common stock	636,004(1)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes (i) 6,004 restricted shares of common stock, par value $0.0001, of the Issuer, of which 3,004 shares are vested and the remainder of which will vest on February 2, 2027, (ii) 315,000 vested restricted stock units ("RSUs"), and (iii) 315,000 unvested RSUs, 2,500 of which will vest on July 2, 2026 and the remainder of which will vest on December 5, 2026.

	/s/ Robert Weinstein	06/25/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)